DAC
CVS icon

Dividend Assets Capital’s CVS Health CVS Stock Holding History

Dividend Assets Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28
Closed -$2K – 199
2023
Q4 		$2K Hold
28
– – ﹤0.01% 459
2023
Q3 		$2K Sell
28
-56
-67% -$3.97K ﹤0.01% 470
2023
Q2 		$6K Sell
84
-244
-74% -$17.4K ﹤0.01% 443
2023
Q1 		$31K Hold
328
– – 0.01% 326
2022
Q4 		$31K Hold
328
– – 0.01% 326
2022
Q3 		$31K Hold
328
– – 0.01% 323
2022
Q2 		$30K Hold
328
– – 0.01% 340
2022
Q1 		$33K Sell
328
-27
-8% -$2.84K 0.01% 333
2021
Q4 		$37K Hold
355
– – 0.01% 314
2021
Q3 		$30K Hold
355
– – 0.01% 335
2021
Q2 		$30K Hold
355
– – 0.01% 348
2021
Q1 		$27K Hold
355
– – 0.01% 360
2020
Q4 		$24K Buy
+355
New +$23.1K ﹤0.01% 363
2018
Q1 		– Sell
-3,215
Closed -$233K – 169
2017
Q4 		$233K Sell
3,215
-147,875
-98% -$10.8M 0.01% 157
2017
Q3 		$12.3M Sell
151,090
-179,224
-54% -$14.2M 0.51% 58
2017
Q2 		$26.6M Sell
330,314
-308,711
-48% -$24.4M 1.05% 44
2017
Q1 		$50.2M Sell
639,025
-532,876
-45% -$42.5M 1.83% 24
2016
Q4 		$92.5M Buy
1,171,901
+121,520
+12% +$9.83M 3.24% 1
2016
Q3 		$93.5M Buy
1,050,381
+309
+0% +$29.2K 2.96% 6
2016
Q2 		$101M Sell
1,050,072
-113,559
-10% -$11.3M 2.98% 7
2016
Q1 		$121M Buy
1,163,631
+11,780
+1% +$1.15M 3.46% 7
2015
Q4 		$113M Buy
1,151,851
+44,619
+4% +$4.37M 3.05% 12
2015
Q3 		$107M Buy
1,107,232
+23,771
+2% +$2.5M 2.71% 15
2015
Q2 		$114M Buy
1,083,461
+52,906
+5% +$5.41M 2.5% 14
2015
Q1 		$106M Buy
1,030,555
+83,240
+9% +$8.42M 2.33% 20
2014
Q4 		$91.2M Buy
947,315
+913,915
+2,736% +$80.5M 2.07% 26
2014
Q3 		$2.66M Buy
+33,400
New +$2.63M 0.07% 62

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dividend Assets Capital's CVS Position: Q1 2024 in Review

Dividend Assets Capital sold out of CVS Health (CVS) in Q1 2024, closing a stake of 28 shares — an estimated $2K sold.

Dividend Assets Capital first reported a position in CVS in Q3 2014 and held it in 27 quarters. The position peaked at $121M in Q1 2016. 2,182 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Dividend Assets Capital reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Dividend Assets Capital sold 28 CVS Health shares in Q1 2024, an estimated $2K.
  • Dividend Assets Capital first reported a position in CVS Health in Q3 2014 and held it in 27 quarters.
  • Dividend Assets Capital's CVS Health position peaked at $121M in Q1 2016.
  • 2,182 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Dividend Assets Capital's 13F filing for Q1 2024, filed 15 May 2024.